Creative Medical Technology Holdings (CELZ) EBITDA Margin Growth (3y) (2020 - 2025)
Creative Medical Technology Holdings (CELZ) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -2,649.00 |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.11 Mn |
| Mar 31, 2025 | -4.77 Mn |
| Dec 31, 2024 | -6.07 Mn |
| Jun 30, 2024 | -1.52 Mn |
| Dec 31, 2023 | -5.72 Mn |
| Sep 30, 2023 | -2.54 Mn |
| Dec 31, 2022 | -4.13 Mn |
| Sep 30, 2022 | -137,980.00 |
| Mar 31, 2022 | -720,562.00 |
| Dec 31, 2021 | -161,749.00 |
| Sep 30, 2021 | -780,987.00 |
| Jun 30, 2021 | 140,054.00 |
| Dec 31, 2020 | 327,830.00 |